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Global prevalence of hepatitis B virus (HBV) infection was 3.5% causing 1.34 
million deaths in 2015. Among six world health organization (WHO) regions, western pacific 
region ranks the most hepatitis B surface antigen (HBsAg) prevalent area having 6.2%. 
Cambodia, one of the developing countries in WHO western pacific region (WHO-WPRO), 
has reported HBsAg prevalence from 3.2 to 8.5% before implementation of hepatitis B 
vaccine (HepB) to national immunization programme (NIP). After phasing-in of HepB 
vaccine in 2005, HBsAg prevalence among ≤ 5 years old children markedly reduced to 
0.33-3.45%. In Cambodia, there is no specific surveillance system on infection control 
including viral hepatitis and no more reports on HBV infection were found after 2011. 
Therefore, in joint collaboration with WHO-WPRO, WHO Cambodia, United State Centers 
for Disease Control and Prevention (US-CDC) and Ministry of Health of Cambodia (MOH), 
Hiroshima University conducted the nationwide study on HBsAg prevalence among 5-7 
years old children and their mothers in 2017. By the nationwide study, the reported HBsAg 
prevalence among 5-7 years old children was 0.56% and that among their mother was 4.39% 
using HBsAg rapid test. The nationwide study revealed the occurrence of HBV infection 
among children who received HepB birth-dose (HB-BD) within 24 hours after delivery and 
demanded further in-detail study on HBV genotype distribution and their mutant variants. 
Therefore, this study aimed to detect HBV genome sequences and their variants as of 
nationwide scale using dried blood spot (DBS) samples and to provide up-to-date reference 
data for infection control and surveillance in Cambodia. 
【Methods】   
Using multi-stage random sampling strategy, the nationally representative 
cross-sectional study was conducted in 2017 and a total of 2,520 children and their 2,028 
mothers were taken by questionnaires, rapid test and their blood samples using dried blood 
spot (DBS). Among them, 2 children samples and 5 mother samples were excluded for their 
insufficient amount of blood for measurement. All samples were tested for HBsAg using 
chemiluminescent enzyme immunoassay (CLEIA). Nucleic acid was directly extracted from 
one fin of HBsAg positive samples using SMITEST. The amplification was carried out by 
nested polymerase chain reaction (nested-PCR) using WA primer set targeting nt1-nt1779 
and nt-1909-nt3215. For the missing portion of HBV circular DNA, second round of nested 
PCR were done using primer set targeting nt1548-nt2097. For those samples that could not 
be amplified at WA primer, second attempt of nested PCR was done targeting s-region. Then, 
direct sequencing was done using 3730xl DNA sequencer with BigDye Terminator v3.1 cycle 
sequencing kit. After analyzing the raw sequences data by GENTYX, the phylogenetic tree 
was employed by neighbor joining method using the standard strains retrieved from 
GeneBank. The recombination of circular DNA was detected using the SimPlot program and 
boost scanning analysis with jumping profile Hidden Markov Model (jpHMM) and visualized 
in a circular form using Circos. The statistical analysis was performed using JMP. The X2 
and Fisher’s exact test were used to compare between group setting significance level at 
p<0.05. 
【Results】   
Using DBS samples, HBsAg positive rate was 4.7% in mothers and 0.52% in their 
children. The mean age of mothers was 32.36±6.01 years. 69.2% of children were 5 years old 
and the rest were 6 years old. Among 95 HBsAg positive mothers, nine of their children were 
positive to HBsAg so that mother-to-child transmission (MTCT) rate was 9.5%. Using DBS 
samples, 75.9% (82/108) of HBsAg positive samples can determine HBV genotype amongst 
which 51.2% (42/82: 32 mothers and 10 children) were full length genomes and the 
remaining were partial genomes. HBV genotype C (80.49%) was abundantly found 
throughout Cambodia whilst genotype B (19.51%) was exclusively found in regions 
bordering Vietnam. Almost all genotype C belong to subtype C1 except one for C8 and 
almost all genotype B are recombinant B4/C2 except one for B2/C2. Full length genome 
analysis revealed the homology of 99.62-100% in each mother-child pair. The overall 
mutation rate of “a determinant region” of S gene among HBV DNA positive sera was 24.3% 
in mothers and 16.7% in children. One mother-child pair has P127S mutation in both 
mothers and children but the other two pairs have mutation only in mother (G145R) or child 
(P120S). The mutation rate of “a determinant region” was higher in children if their mother 
was infected with mutant variants (5.9% Vs 1.9%, p=0.39) or if they received HepB vaccine 
(28.57% Vs 0.00%, p=0.21). The double mutation (A1762T/G1764A) in C1 strains was 
48.39% and that of combination mutation C1653T or T1753C and A1762T/G1764A.  
【Discussion】 
This is the first report on genotype distribution of HBV and the existence of mutant 
strains in “a determinant region of S gene as of its nationwide scale in Cambodia. Both 
partial and full-length HBV genomes can be extracted from DBS which confer up to large 
scale molecular epidemiological study of HBV especially in resource limited settings. The 
evolutionary analysis of HBV genomes revealed its historical relation among neighboring 
countries. Understanding of predominant genotypes aware its geographic variation and 
calls for implementation of area-specific effective infection control against HBV. Existence of 
mutant strains in “a determinant region” of S gene alert the potential breakthrough 
infection among immunized children. 99.62-100% homology of HBV strains from 
mother-child pairs strongly demands to promote mother-to-child prevention strategies on 
HBV in Cambodia. Moreover, the occurrence of double and combination mutation in C1 
strains isolated in this study which are significantly related to hepatocellular carcinogenesis 
superimposes the needs of effective infection control and its surveillance system including 
PMTCT so that Cambodia can straightforwardly move to WHO’s elimination goal of viral 
hepatitis by 2030. 
 
